King Pharmaceuticals KG Workers' Compensation — Year 7
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearSeven.
The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's workers' compensation — year 7.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's workers' compensation — year 7?
- King Pharmaceuticals (KG) reported workers' compensation — year 7 of 2.5% in Q4 2025.
- What does workers' compensation — year 7 mean?
- This metric captures the revenue or performance of the Workers' Compensation insurance segment in the seventh year. It helps stakeholders assess the long-term viability and competitive positioning of this specific insurance offering.